Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?
Sian Bradley(UNSW Sydney), Sonu Bhaskar(New South Wales Department of Health), Man Mohan Mehndiratta(BLK Super Speciality Hospital), Bindu Menon(Apollo Hospitals), Francis Muttamthottil Varghese(Chaithanya Eye Hospital and Research Institute)
Cited by 1
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
|Frontiers in Immunology|2020|519
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
|Particle and Fibre Toxicology|2010|491
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|373